The inconsistency for the activity of miR-195 in regulating FASN expression between our study and a previous report [25] is likely due to some subtle difference between breast cancer and osteosarcoma, such as difference in cellular protein composition and microenvironment. The gene discussed is FASN; the disease is breast carcinoma.